Beacon Pointe Advisors’s Theratechnologies THTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-26,525
Closed -$62.6K 1521
2025
Q2
$62.6K Hold
26,525
﹤0.01% 1237
2025
Q1
$37.1K Hold
26,525
﹤0.01% 1204
2024
Q4
$48K Hold
26,525
﹤0.01% 1188
2024
Q3
$32.9K Hold
26,525
﹤0.01% 1206
2024
Q2
$37.1K Hold
26,525
﹤0.01% 1248
2024
Q1
$44K Buy
26,525
+500
+2% +$802 ﹤0.01% 1333
2023
Q4
$42.2K Hold
26,025
﹤0.01% 1300
2023
Q3
$56K Buy
+26,025
New +$55.7K ﹤0.01% 1305

Other funds holding THTX

Beacon Pointe Advisors's THTX Position: Q3 2025 in Review

Beacon Pointe Advisors sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 26,525 shares — an estimated $62.6K sold.

Beacon Pointe Advisors first reported a position in THTX in Q3 2023 and held it in 8 quarters. The position peaked at $62.6K in Q2 2025. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • Beacon Pointe Advisors reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • Beacon Pointe Advisors sold 26,525 Theratechnologies shares in Q3 2025, an estimated $62.6K.
  • Beacon Pointe Advisors first reported a position in Theratechnologies in Q3 2023 and held it in 8 quarters.
  • Beacon Pointe Advisors's Theratechnologies position peaked at $62.6K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on Beacon Pointe Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.